Shopping Cart
- Remove All
- Your shopping cart is currently empty
CDK12-IN-6, a pyrazolotriazine compound, is a powerful inhibitor of CDK12. Its inhibitory activity is significant with an IC50 value of 1.19 μM when tested at high ATP concentration (2 mM). Notably, CDK12-IN-6 does not exhibit any inhibitory effect on CDK2/Cyclin E (IC50 >20 μM) and CDK9/Cyclin T1 (IC50 >20 μM) when tested under the same high ATP conditions (2 mM) (WO2021116178A1).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | Backorder |
Description | CDK12-IN-6, a pyrazolotriazine compound, is a powerful inhibitor of CDK12. Its inhibitory activity is significant with an IC50 value of 1.19 μM when tested at high ATP concentration (2 mM). Notably, CDK12-IN-6 does not exhibit any inhibitory effect on CDK2/Cyclin E (IC50 >20 μM) and CDK9/Cyclin T1 (IC50 >20 μM) when tested under the same high ATP conditions (2 mM) (WO2021116178A1). |
Targets&IC50 | CDK12:1.19 μM (IC50), CDK2-CyclinE:>20 μM (IC50), CDK9-CyclinT1:>20 μM (IC50) |
In vitro | CDK12-IN-6 (Example 174) suppresses BRCA1 mRNA expression in MDA-MB-231 cells with an IC50 of 0.872 nM, while having no impact on CAL-120 cells. It also demonstrates antiproliferative effects in both MDA-MB-231 (IC50 = 2.19 nM) and CAL-120 cells (IC50 = 1 nM). Moreover, CDK12-IN-6 exhibits high CDK12 inhibition efficiency with an IC50 to DC50 ratio of 1851, indicating potent activity in hindering CDK12 in ATP to degradation processes. |
Alias | CDK12-IN-6 |
Molecular Weight | 425.448 |
Formula | C20H21F2N9 |
Cas No. | 2651196-71-1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.